Friday, September 21, 2018

Earth Science Tech, Inc. (ETST) Sees Uplisting to OTCQB Venture Market as Key to Goal of being Global Leader in Cannabinoid Market

  • Biotech company is focused on becoming a worldwide leader in R&D and sale of hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary supplements
  • ETST is developing three new CBD formulas in Canada under a provisory patent; it is also clinical testing its Hygee medical device for detecting sexually transmitted diseases in women
  • With its Form 10 Registration Statement filing now effective, ETST will begin reporting annual, quarterly and periodic financial statements
Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its uplisting to the OTCQB Venture Market will enable it to reach global recognition and increase liquidity as a leader in the hemp-based CBD space in several fields, such as cannabinoid products. It also develops innovative medical devices designed for multi-national marketing (http://nnw.fm/RZx3Y).
The Florida-based company seeks to raise its recognition level and perform more R&D for the CBD industry. ETST manufactures, markets and distributes its own cannabinoid products, including capsules and oils. It is a leader in the medical cannabis markets, with its products available at retail health food stores and e-liquid smoke shops.
“Historically, up-listing to the OTCQB and being fully reporting has resulted in greater liquidity and awareness,” Nickolas S. Tabraue, president, director and chairman of ETST, stated in a news release (http://nnw.fm/Z9kJ0). “We are committed to the higher level of corporate and financial disclosures required as an OTCQB fully reporting company, demonstrating our commitment to our loyal shareholders.”
In Canada, it is testing three new CBD IP formulations. It is also clinical testing its Hygee MSN-2 medical device for detection of sexually transmitted infections (STIs) in women at Québec’s Clinique Santé Amitié (http://nnw.fm/g4vqP).
It is developing two new products in Brazil in a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division Bionatus Botanical Laboratories, Inc. In the U.S., it is conducting studies with the University of Central Oklahoma on the impact of high grade full spectrum CBD on immune cells and breast cancer (http://nnw.fm/gJqL6).
ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit and accepts grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company that provides ETST with access to government grants.
For more information, visit the company’s website at www.EarthScienceTech.com
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

No comments:

Post a Comment